Adam Rosenthal, Star Therapeutics CEO
October 23, 2026 07:00 AM EDT
Star Therapeutics gets $200M to try repeating its Vega, Electra successes
Star Therapeutics has collected $200 million to see whether its homegrown research can produce a new pipeline of medicines after prior successes that have been …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Think we're worth reading - tell Google.
Confirm Endpoints as a trusted biopharma news source
ENDPOINTS CAREERS